Neuphoria TherapeuticsNEUP
13F holders, Q3 2025 (September 30)15holders +6
9new positions
3sold out
1famous investor
$11.79avg. 13F price*
At the end of Q3 2025, 15 institutions reported holding Neuphoria Therapeutics Inc. (NEUP) in their 13F filings, up 6 from Q2 2025. 9 opened new positions and 3 sold out. The largest holders were AdvisorShares Investments LLC ($690K), Prosperity Wealth Management, Inc. ($352K) and Diadema Partners LP ($253K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Neuphoria Therapeutics Inc.
- CUSIP
- 64136E102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $1.1M |
| Exits | 3 | $500K |
All 13F filers, Q2 2025 → Q3 2025: 96,957 shares bought and 79,582 shares sold, net +17,375 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| AdvisorShares Investments LLC | 0.11% | Reduce -13.5% | 58,563 | $690K |
| Prosperity Wealth Management, Inc. | 0.12% | Add +0.3% | 29,825 | $352K |
| Diadema Partners LP | 0.18% | New | 21,452 | $253K |
| Vanguard Group Inc. | 0.00% | New | 20,950 | $247K |
| Millennium Management | 0.00% | New | 18,329 | $216K |
| Jane Street Group, LLC | 0.00% | New | 15,669 | $185K |
| Geode Capital Management, LLC | 0.00% | New | 12,978 | $153K |
| Merck & Co., Inc. | 0.05% | No change | 10,027 | $118K |
| Persistent Asset Partners Ltd | 0.04% | New | 4,908 | $58K |
| UBS Group AG | 0.00% | New | 2,168 | $26K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 410 | $5K |
| Rhumbline Advisers | 0.00% | No change | 33 | $389 |
| Bank of America Corp. | 0.00% | Add +1600.0% | 17 | $201 |
| Morgan Stanley | 0.00% | No change | 7 | $83 |
| FMR LLC | 0.00% | New | 2 | $24 |
"% of holder's portfolio" is NEUP's weight in each manager's 13F, not the share of Neuphoria Therapeutics Inc. the manager owns.